Startups
Endomedix is a development stage MedTech firm that has developed a platform technology (PLEXimine™) based on novel polysaccharide chemistry. PLEXimine forms devices in situ that are structured and dynamic 3D networks. This technology is versatile and can produce an array of different properties for use in the development of a series of separate product categories. Endomedix has been awarded 7 NIH SBIR & 1 NYS grants, and has obtained 9 issued patents based for this technology. The first device using this technology will be PlexiClot™ Absorbable Hemostat for brain & spinal surgeries, an underserved $1.7B niche. PlexiClot addresses major unmet needs in these high value surgeries with a unique technology that cannot be equaled by existing technologies. Additionally, the Company has entered into a Cooperative Research and Development Agreement (CRADA) with the US Army Medical Materiel Development Command (USAMMC) for the development of a treatment system for ocular projectile battlefield trauma using PLEXimine technology. In addition to grants, the Company has raised $3.3 M in private investment.
Overview
Location
United States, New Jersey, Montclair
Employees
1-10
Founded date
2005
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| A device to control bleeding in brain surgery receives Phase 2 SBIR grant | A medical device developer got a big boost in its efforts to develop a surgical sealant for brain surgery. Endomedix received a $1.49 million Phase 2 Small Business Innovation Research grant to help control bleeding for surgical procedures,... |
Reviews 0
FAQ about Endomedix
When was Endomedix founded?
Endomedix was founded in 2005.
What has the press written about Endomedix?
Parsers VC has collected 2 articles mentioning Endomedix, among them “A device to control bleeding in brain surgery receives Phase 2 SBIR grant”.
Is Endomedix still active?
Yes, Endomedix is active; its latest activity on Parsers VC dates from Jul 10, 2026.